TGFB1 and neoplasm: It is pointed out that platelet-derived TGF-β could synergistically activate the TGF-β/Smad signaling and NF-κB pathways in tumor cells, and that abrogation of TGF-β signaling was sufficient to inhibit metastasis and EMT (68).